Company: RGBP
Filing Date: 2025-12-05
Form Type: 253G1
Source: 0001493152-25-026350
Chunk: 120

Company: Regen BioPharma Inc
Filing Date: 2025-12-05
Form: 253G1
Chunk 120
---
 $ |       1,708 |     | $ |        1,708 |
| BST                              
 Partners                         |     |   |      46,599 |     |   |            - |
| Zander                           
 Therapeutics, Inc.               |     |   |      59,200 |     |   |       40,000 |
| Total                            
 notes payable to related parties |     | $ |     107,507 |     | $ |       41,708 |

$1,708 lent to the Company by David Koos is due and payable at the demand of the holder and bears simple interest at a rate of 15% per annum.

$15,000 lent to the Company by Zander Therapeutics, Inc. is due and payable on May 3. 2025 and bears simple interest at a rate of 10% per annum.

$25,000 lent to the Company by Zander Therapeutics, Inc. is due and payable on June 5. 2025 and bears simple interest at a rate of 10% per annum.

$10,000 lent to the Company by Zander Therapeutics, Inc. is due and payable on October 4, 2025 and bears simple interest at a rate of 10% per annum.

$4,700 lent to the Company by Zander Therapeutics, Inc. is due and payable on October 15 2025 and bears simple interest at a rate of 10% per annum.

$4,500 lent to the Company by Zander Therapeutics, Inc. is due and payable on October 23 2025 and bears simple interest at a rate of 10% per annum.

Zander Therapeutics, Inc, and the Company are under common control.

During the quarter ended December 31, 2024 BST Partners lent the Company the $46,599 and bears simple interest at a rate of 10% per annum..

BST Partners and the Company are under common control.

(b) NON RELATED PARTY

Notes payable consisted of the following:

|                                     |     | As       
 of       
 December 
 31, 2024 |   |     | As        
 of        
 September 
 30, 2024  |         |   |
|:------------------------------------|:----|:---------|:--|:----|:----------|--------:|:--|
| Bostonia                            
 Partners, Inc.                      |     | $        | - |     | $         |  48,500 |